Pharmacovigilance Press

Introduction

Soon for your needs!

Pharmacovigilance started in 1961, and since then a lot has changed.
Pharmacovigilance (PV) is not only an obligation for all Marketing Authorisation Holders (MAHs) and Sponsors of clinical trials but also an important requirement in order to protect public health.

The purpose of the PV Press is to provide to our readers, tools and themes of discussion on pharmacovigilance hot topics, original research and review articles about the pharmaceutical intervention safety. The PV Press aims to follow ongoing updates and to fill all the important knowledge gaps.

Information received from health care professionals, patients, digital media, electronic health records, real world data and pharma companies via conferences, courses as well as other sources such as the medical literature, plays a critical role in providing the data necessary for pharmacovigilance.

Pharmacovigilance is also concerned with identifying the hazards associated with pharmaceutical products and with minimizing the risk of any harm that may come to patients. Companies must conduct a comprehensive drug safety and pharmacovigilance audit/inspection to assess their compliance with worldwide laws, regulations, and guidance.
The possibility to having a tool that keeps our readers up to date on the changes and the ability to launch discussion on hot topics, facilitates daily work and would be an easy consultation tool.

PV Press wants to give precise answers to the needs of our readers.

You will be in the forefront of the realization of this magazine that meets your needs.
Give us your insights and be part of it!

For further information please contact:


Annalisa De Biasi

Project and Scientific Manager

LS Academy – EASYB S.r.l.
Via Roma, 20 – 24022 Alzano Lombardo BERGAMO – Italy
Tel. (+39) 035.515684 cell. (+39) 328.4987130 Fax: (+39) 035.4501262

e-mail: annalisa.debiasi@lsacademy.it